Minimal Clinically Important Differences in the Six-Minute Walk Test and the Incremental Shuttle Walking Test

作者: Robert A Wise , Cynthia D Brown

DOI: 10.1081/COPD-200050527

关键词:

摘要: Simple walking tests are widely used for the assessment of functional status in patients with cardiorespiratory disorders. These require far less instrumentation than formal cardiopulmonary exercise tests, but they do standardization procedures to achieve reproducible results. The most COPD 6-minute test (6MWT) and incremental shuttle (SWT). 6MWT has been characterized respect reproducibility responsivity change health status. results correlated pulmonary function, health-related quality life, maximum capacity, mortality. minimal clinically important difference (MCID) is conservatively estimated be 54-80 meters using both distributional discriminative methods. For an individual patient, would need by about 86 statistically confident that there a change. SWT extensively validated 6MWT, similar (CV = approximately 20%). improve rehabilitation bronchodilation, highly oxygen consumption. There no studies address issue MCID SWT. In addition MCID, design interpretation clinical trials should take into account severity initial impairment, asymmetry between positive negative changes, proportion who show substantial improvement, costs risks treatment.

参考文章(35)
A Kadikar, J Maurer, S Kesten, The six-minute walk test : A guide to assessment for lung transplantation Journal of Heart and Lung Transplantation. ,vol. 16, pp. 313- 319 ,(1997)
Carlo Rostagno, Giuseppe Olivo, Marco Comeglio, Vieri Boddi, Michela Banchelli, Giorgio Galanti, Gian Franco Gensini, Prognostic value of 6-minute walk corridor test in patients with mild to moderate heart failure: comparison with other methods of functional evaluation. European Journal of Heart Failure. ,vol. 5, pp. 247- 252 ,(2003) , 10.1016/S1388-9842(02)00244-1
Geoffrey R. Norman, Jeff A. Sloan, Kathleen W. Wyrwich, Interpretation of changes in health-related quality of life the remarkable universality of half a standard deviation Medical Care. ,vol. 41, pp. 582- 592 ,(2003) , 10.1097/01.MLR.0000062554.74615.4C
G.H. Guyatt, M. Townsend, J. Keller, J. Singer, S. Nogradi, Measuring functional status in chronic lung disease: conclusions from a randomized control trial Respiratory Medicine. ,vol. 83, pp. 293- 297 ,(1989) , 10.1016/S0954-6111(89)80199-4
Geoffrey R Norman, Jeff A Sloan, Kathleen W Wyrwich, The truly remarkable universality of half a standard deviation: confirmation through another look Expert Review of Pharmacoeconomics & Outcomes Research. ,vol. 4, pp. 581- 585 ,(2004) , 10.1586/14737167.4.5.581
Marius M. Hoeper, Michael Schwarze, Stefan Ehlerding, Angelika Adler-Schuermeyer, Edda Spiekerkoetter, Jost Niedermeyer, Michael Hamm, Helmut Fabel, Long-Term Treatment of Primary Pulmonary Hypertension with Aerosolized Iloprost, a Prostacyclin Analogue The New England Journal of Medicine. ,vol. 342, pp. 1866- 1870 ,(2000) , 10.1056/NEJM200006223422503
Gordon H. Guyatt, Penelope J. Thompson, Leslie B. Berman, Michael J. Sullivan, Marie Townsend, Norman L. Jones, Stewart O. Pugsley, How should we measure function in patients with chronic heart and lung disease Journal of Chronic Diseases. ,vol. 38, pp. 517- 524 ,(1985) , 10.1016/0021-9681(85)90035-9
R J Butland, J Pang, E R Gross, A A Woodcock, D M Geddes, Two-, six-, and 12-minute walking tests in respiratory disease. BMJ. ,vol. 284, pp. 1607- 1608 ,(1982) , 10.1136/BMJ.284.6329.1607
Les A. Szekely, David A. Oelberg, Cameron Wright, Douglas C. Johnson, John Wain, Beatrice Trotman-Dickenson, Jo-Anne Shepard, David J. Kanarek, David Systrom, Leo C. Ginns, Preoperative Predictors of Operative Morbidity and Mortality in COPD Patients Undergoing Bilateral Lung Volume Reduction Surgery Chest. ,vol. 111, pp. 550- 558 ,(1997) , 10.1378/CHEST.111.3.550
RS Goldstein, EH Gort, MA Avendano, D Stubbing, GH Guyatt, Randomised controlled trial of respiratory rehabilitation The Lancet. ,vol. 344, pp. 1394- 1397 ,(1994) , 10.1016/S0140-6736(94)90568-1